Date | Price Target | Rating | Analyst |
---|---|---|---|
9/22/2023 | $108.00 | Overweight | JP Morgan |
6/30/2023 | $138.00 | Buy | BofA Securities |
12/14/2021 | $120.00 | Market Perform → Market Outperform | CJS Securities |
8/6/2021 | $130.00 → $139.00 | Outperform | Barrington Research |
Barrington Research analyst Michael Petusky maintains US Physical Therapy (NYSE:USPH) with a Outperform and maintains $122 price target.
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.56 by 8.93 percent. This is a 13.56 percent decrease over earnings of $0.59 per share from the same period last year. The company reported quarterly sales of $155.675 million which beat the analyst consensus estimate of $153.366 million by 1.51 percent. This is a 4.83 percent increase over sales of $148.509 million the same period last year.
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G/A - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
SC 13G - U S PHYSICAL THERAPY INC /NV (0000885978) (Subject)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
8-K - U S PHYSICAL THERAPY INC /NV (0000885978) (Filer)
JP Morgan initiated coverage of U.S. Physical Therapy with a rating of Overweight and set a new price target of $108.00
BofA Securities initiated coverage of U.S. Physical Therapy with a rating of Buy and set a new price target of $138.00
CJS Securities upgraded U.S. Physical Therapy from Market Perform to Market Outperform and set a new price target of $120.00
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
4 - U S PHYSICAL THERAPY INC /NV (0000885978) (Issuer)
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with eight clinic locations located in Pennsylvania which currently generates approximately $5.5 million in annual revenues. The Company acquired a 70% interest in the Company with the current owners retaining a 30% ownership interest. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 687 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a
U.S. Physical Therapy, Inc. (the "Company) (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today announced that Chris Reading, the Company's Chairman and Chief Executive Officer, will present at the 15th Annual Midwest IDEAS Investor Conference on Wednesday, August 28, 2024. The presentation will cover an overview of the Company. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 680 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries,
Reports All-Time High Quarterly Patient Volume Management Updates Guidance U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the three and six months ended June 30, 2024. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $22.1 million for the three months ended June 30, 2024 ("2024 Second Quarter") compared to $21.7 million in the second quarter ended June 30, 2023 ("2023 Second Quarter"). Operating Results (1), a non-GAAP measure, was $11.0 million in the 2024 Se
EAGAN, Minn., June 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ:POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development, today announced the appointment of Dr. Bernard A. Harris, Jr. to its newly-formed Business Advisory Board (BAB). "I am very pleased to welcome Dr. Harris to our new Business Advisory Board," said Raymond F. Vennare, Chief Executive Officer of Predictive Oncology. "As we continue
~Highly Esteemed Growth Strategist and Financial Expert with Decades of Business Acumen~ NEW YORK, Oct. 18, 2022 /PRNewswire/ -- The National Kidney Foundation (NKF) is pleased to announce the appointment of Anne Motsenbocker to its national Board of Directors. We're honored & excited Anne has joined the national board to share her extensive business acumen in board governance.Motsenbocker resides in Dallas, Texas and is a former banker and seasoned board member bringing over 35 years of commercial banking and wealth management expertise due to the numerous roles she held at J
HOUSTON, June 10, 2022 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled healthcare services company comprised of a hospital division with 21 facilities in 8 states and a primary care-centric, risk-bearing population health management division, today announced the appointment of Jon Bates as the Company's Chief Financial Officer effective on or about June 30, 2022. On May 3, 2022, Michael Bowen notified the company that he intends to retire as Chief Financial Officer of the Company. In connection with Mr. Bowen's retirement, the Company's Board formed a search committee. On June 8, 2022, the Company announced the appointme
U.S. Physical Therapy, Inc. (the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced the acquisition of a physical therapy and hand therapy practice with eight clinic locations located in Pennsylvania which currently generates approximately $5.5 million in annual revenues. The Company acquired a 70% interest in the Company with the current owners retaining a 30% ownership interest. About U.S. Physical Therapy, Inc. Founded in 1990, U.S. Physical Therapy, Inc. operates 687 outpatient physical therapy clinics in 42 states. The Company's clinics provide preventative and post-operative care for a
U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the three and six months ended June 30, 2024, on Tuesday, August 13, 2024, after the stock market closes, with the conference call to follow the next morning, on Wednesday, August 14, 2024. Conference Call Date: Wednesday, August 14, 2024 Time: 10:30 am Eastern/9:30 am Central Dial-In Number: (800) 245-3047 Primary or (203) 518-9765 Alternate Conference ID: USPHQ224 (In order to join this conference call,
Management Raises Full Year 2024 Guidance U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, today reported results for the first quarter ended March 31, 2024. FINANCIAL HIGHLIGHTS Adjusted EBITDA (1), a non-Generally Accepted Accounting Principles ("GAAP") measure, was $16.7 million for the first quarter ended March 31, 2024 ("2024 First Quarter") compared to $18.5 million in the first quarter ended March 31, 2023 ("2023 First Quarter"), with the variance due to the Medicare rate reductions that took effect at the beginning of 2024 and the impact of signi